This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Injectable Benzodiazepine Market

Market Insights on Injectable Benzodiazepine covering sales outlook, demand forecast & up-to-date key trends

Injectable Benzodiazepine Market By Drug Class (Diazepam, Lorazepam, Midazolam), Time of Action (Short Acting, Long Acting), Indication (Agitation & Aggression, Anxiety, Alcohol Withdrawal, Muscle Spasm), Distribution Channel (Hospital, Ambulatory Surgical centers, Diagnostics Centers) & Region - Forecast to 2020-2030

Injectable Benzodiazepines Market Outlook & Key Findings

  • Injectable benzodiazepines market expected to grow at over 2.7 % in 2020. Increasing adoption of generic injectable benzodiazepine drugs to be a key growth driver
  • Low profitability margin remains a challenge for injectable benzodiazepines market players
  • Outbreak of Covid-19 to increase the short-term demand for injectable benzodiazepine drugs as anxiety levels increase in general population
  • Short-acting injectable benzodiazepines gaining traction

Growing Incidences of Mental Disorders to Drive the Market

Injectable benzodiazepine drugs are administered as the first course of treatment with regards to mental disorders like depression, bipolar disorder, schizophrenia, dementia, anxiety disorder, autism.

The WHO, European Brain Council (EBC), and European College of Neuropsychopharmacology (ECNP) state that around 25% of the global population encounters mental disorders at least once in their lifetime.

As per NSDUH (National Survey on Drug Use and Health), in 2017, close to 46.6 million adults suffered from mental disorders (up by 1.5% in 2010) in the US. So, it could be inferred that 18-20% of the people in the US suffer from mental disorders, which are expected to account for the largest share of injectable benzodiazepines market in the forecast period.

As per the WHO, in the year 2017, around 35-40% of people in the EU were affected with mental disorders. Besides, as of 2015, increase in chronic depression resulted in higher absenteeism coupled with lower productivity at work. This lacuna had cost EU US$47.04 Billion Tn 2015.

On the other hand, India, in 2017, accounted for almost 15% of the global neurological, mental, and substance abuse disorders. In Asia-Pacific on the whole, more than 68% of the people are reported to have psychiatric disorders. This figure is expected to have Asia Pacific witness the highest growth rate in terms of injectable benzodiazepines.

As per the Anxiety and Depression Association of America, around 40 million adults of the US get affected by anxiety disorders every year. The medical fraternity states that the number of mental disorders would increase in the near future due to less attention being paid to self-talk.

All the facts mentioned above are expected to drive the injectable benzodiazepines market in the years to come.

Customize this Report

Let us know your requirement to get
100% FREE customization

Generics Leading the Injectable Benzodiazepine Market Space Over Lower Price Point

Injectable benzodiazepine market is subject to fierce competition due to increasing adoption of generic injectables that prove to be cost-effective as compared to their branded counterparts. As per the Association of Accessible Medicines, branded drugs account for around 77% of the overall spending on prescriptions with merely 10% of those prescriptions getting filled.

Also, in the year 2017, generics saved close to US$ 265 billion through generics. These generics corresponded to treatment for hypertension, ulcer, cholesterol, and mental health.

Generic diazepam, midazolam, and lorazepam drugs are prescribed for seizures, insomnia, and anxiety. These generic medications are expected to boost the injectable benzodiazepines market in the forecast period.

Injectable Benzodiazepines Market Remains Consolidated

The inorganic modes of expansion include technology and distribution agreements, product improvement, and partnerships. These moves are expected to give an impetus to the market in the forecast period.

For instance – Xeris Pharmaceuticals, in Apr 2020, announced positive results out of their Phase 1b weight-based dosing study regarding diazepam intramuscular (IM) injection by using XeriSol technology.

In Dec, 2019, Eton Pharmaceuticals, Inc. announced commercial availability of Biorphen, an injectable benzodiazepine, for treating hypotension.

“SUBLOCADE”, a buprenorphine extended-release injection, is available in the US since Mar 2018 post approval from the US FDA for treating OUD (opioid use disorder).

Short-Acting Injectable Benzodiazepines Gaining Traction

Increasing demand for short-acting injectable benzodiazepines due to faster excretion and immediate action is resulting in higher level of supervised administration.

Panic disorders are reported to affect around 2.7% of the US population. Muscle spasm and alcohol withdrawal also call for short acting injectable benzodiazepine drugs.

Plus, feasible scenario relating to reimbursement has made these healthcare solutions affable. These measures are expected to upscale the market in the forecast period.

Covid-19 Crisis to Bolster the Market Short-Term

The outbreak of Covid-19 has raised uncertainties, which have led to the onset of various mental disorders.

For instance – in Italy, the basic concern revolves around managing family and children along with maintenance of own borders and spaces. Developing economies like Brazil aren’t getting any active support on the count of addressing mental illnesses. Professional institutions need to come into picture to address this.

In the UK, the worrisome issues include uncertain future, anxiety/stress, and getting bored. Over 63% of the population of the UK is concerned about what is exactly in store for them. This factor is bound to raise the number of cases relating to mental stress.

In countries like India, almost 33% of the entire population has admitted to have a pessimistic impact of Covid-19 as joblessness has set in. Those working on daily wages and also the ones in field jobs have already lost out on their source of income; which is making inroads for depression and anxiety.

In the US, over 30% of people have been reported to get mentally affected by Covid-19. As the future looks bleak, people are getting drawn towards being mentally blank. Along with the professional concerns, there are personal concerns like coping up with the corporate lifestyle. A vacuum is getting created involuntarily; which is adding to the stress.

The factors mentioned above are expected to drive the market for injectable benzodiazepines in the next few months.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Stringent Regulations and Misuse of Injectable Benzodiazepines: Key Challenges to Injectable Benzodiazepines Market

There only a handful of patented injectable benzodiazepines that fall in the “branded” category. As such, procuring and developing the ingredients could prove to be complex. Besides, stringent regulations regarding quality assessment may hamper the market.

Also, intake of these drugs without proper medical advice may prove to be fatal. Since the year 2010, overdose of benzodiazepines has resulted in 6507 deaths in the US. Also, in Sweden, a study was conducted wherein it was revealed that benzodiazepines are the drugs with majority of forged prescriptions.

This factor also proves to be a restraint with respect to the growth of the market.

Injectable Benzodiazepines Market: Region-wise Analysis

Injectable Benzodiazepine Market Download Report Brochure

North America and Europe hold the largest market share in injectable benzodiazepines mainly due to increasing adoption of generic injectable benzodiazepines. The US is expected to witness around 2.8% growth in 2020. In Latin America, anxiety and alcohol withdrawal symptoms are driving the market and expected to do so in the forecast period as well.

Asia Pacific is witnessing mass production of generic injectable benzodiazepines, which will facilitate its fastest growth rate in the upcoming period. Oceania and MEA are still in the growth phase.

Leading Players in Injectable Benzodiazepines Market

The injectable benzodiazepines market is in the consolidation phase; with 15+ players involved in extensive research and capacity expansion to maintain a strong foothold in the market.

One such study was conducted in Sweden in Apr 2020 to look into the association between paternal and maternal mental disorders with risk of injuries in the adolescents and children. On the similar grounds, a new study by Boston Medical Center revealed that 1 in 3 people receive medication related to opioid use disorder, that too, within a year of non-fatal overdose of the same. Likewise, studies are being conducted across the globe to look for advantages of injectable benzodiazepines and their application in the broader scenario.

The key players in the injectable benzodiazepines market include:

Americas

  • Pfizer Inc.
  • Akorn Inc
  • Dash Pharmaceuticals LLC
  • AdvaCare Pharma

Europe

  • Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • F. Hoffmann-La Roche Ltd
  • Hameln pharma ltd
  • Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.)
  • Accord Healthcare Ltd

Asia Pacific

  • Sun Pharmaceutical Industries Limited
  • Taj Pharmaceuticals Limited
  • Troy Laboratories Pty Ltd
  • Intas Pharmaceuticals Limited
  • Martin Dow

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report

Injectable Benzodiazepines: The Way Forward

The injectable benzodiazepines market, in the long run, shows optimism, with FMI’s analysis predicting a steady growth rate of 2.7% in the forecast period. Covid-19 pandemic will also see an upswing in the market for the subsequent months. At the same time, growing adoption of generic drugs is another factor providing traction to the market.

The manufacturers are needed to emphasize on production and cost management for addressing drug shortages and also reach out to wider geographies. Auto-injector technology, if put into practice, is bound to reach more number of people within no time. Also, players will have to collaborate with the governments to reform the regulations; so that more such drugs could be tabled.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments of Injectable benzodiazepines Market

FMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

  • Diazepam
  • Lorazepam
  • Midazolam

Time of Action

  • Short Acting
  • Long Acting

Indication

  • Agitation & Aggression
  • Anxiety
  • Alcohol Withdrawal
  • Muscle Spasm
  • Seizures
  • Tetanus
  • Sedation
  • Anaesthesia
  • Insomnia
  • Status Epilepticus

Distribution Channel

  • Hospital
  • Ambulatory Surgical centers
  • Diagnostics Centers

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The injectable benzodiazepines market is expected to grow at a 2.7% CAGR from 2022 to 2032

By 2022-end, injectable benzodiazepines sales are likely to reach US$ 274 Million

By 2032-end, injectable benzodiazepines sales are likely to reach US$ 356Million

Pfizer Inc., Akorn Inc, and Sun Pharmaceutical Industries Limited are some leading injectable benzodiazepines market vendors.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Per Capita Healthcare Expenditure Outlook

        4.1.3. Overall Psychoactive Drugs Market

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Increasing Incidence of Anxiety, Seizures, Insomnia

        4.2.2. Increasing Usage as Anaesthesia

        4.2.3. Dose Per Case

        4.2.4. Treatment Cost

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. Market Context

    5.1. Product Adoption / Usage Analysis By Indication

    5.2. Disease Epidemiology, By Region

    5.3. Regulatory Scenario

    5.4. Reimbursement Landscape

    5.5. Key Promotional Strategies, By Manufacturers

    5.6. COVID19 Crisis Analysis

        5.6.1. Current COVID19 Statistics and Probable Future Impact

        5.6.2. Current GDP Projection and Probable Impact

        5.6.3. COVID19 and Impact Analysis

            5.6.3.1. Revenue By Class

            5.6.3.2. Revenue By Country

        5.6.4. 2020 Market Scenario

        5.6.5. Quarter by Quarter Forecast

        5.6.6. Projected recovery Quarter

        5.6.7. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Injectable Benzodiazepines Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Opportunity Analysis, 2020-2030

7. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Class

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Drug Class , 2015–2019

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class , 2020-2030

        7.3.1. Diazepam

        7.3.2. Lorazepam

        7.3.3. Midazolam

    7.4. Market Attractiveness Analysis By Drug Class

8. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 - 2018

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 - 2030

        8.3.1. Agitation & Aggression

        8.3.2. Anxiety

        8.3.3. Alcohol Withdrawal

        8.3.4. Muscle Spasm

        8.3.5. Seizures

        8.3.6. Tetanus

        8.3.7. Sedation

        8.3.8. Local Anaesthesia

        8.3.9. Insomnia

        8.3.10. Status Epilepticus

    8.4. Market Attractiveness Analysis By Indication

9. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Time of Action

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Time of Action, 2014 - 2018

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Time of Action, 2019 - 2030

        9.3.1. Short Acting

        9.3.2. Long Acting

    9.4. Market Attractiveness Analysis By Time of Action

10. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2018

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2030

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Mail Order Pharmacies/Online Pharmacies

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        12.3.1.  By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Drug Class

        12.3.3. By Indication

        12.3.4. By Time of Action

        12.3.5. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        13.3.1.  By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Drug Class

        13.3.3. By Indication

        13.3.4. By Time of Action

        13.3.5. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        14.3.1.  By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Drug Class

        14.3.3. By Indication

        14.3.4. By Time of Action

        14.3.5. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        15.3.1.  By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Drug Class

        15.3.3. By Indication

        15.3.4. By Time of Action

        15.3.5. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Drug Class

        16.3.3. By Indication

        16.3.4. By Time of Action

        16.3.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Drug Class

        17.3.3. By Indication

        17.3.4. By Time of Action

        17.3.5. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. Rest of Middle East and Africa

        18.3.2. By Drug Class

        18.3.3. By Indication

        18.3.4. By Time of Action

        18.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Injectable Benzodiazepines Market Analysis

        19.2.1. By Drug Class

        19.2.2. By Indication

        19.2.3. By Time of Action

        19.2.4. By Distribution Channel

    19.3. Canada Injectable Benzodiazepines Market Analysis

        19.3.1. By Drug Class

        19.3.2. By Indication

        19.3.3. By Time of Action

        19.3.4. By Distribution Channel

    19.4. Mexico Injectable Benzodiazepines Market Analysis

        19.4.1. By Drug Class

        19.4.2. By Indication

        19.4.3. By Time of Action

        19.4.4. By Distribution Channel

    19.5. Brazil Injectable Benzodiazepines Market Analysis

        19.5.1. By Drug Class

        19.5.2. By Indication

        19.5.3. By Time of Action

        19.5.4. By Distribution Channel

    19.6. U.K. Injectable Benzodiazepines Market Analysis

        19.6.1. By Drug Class

        19.6.2. By Indication

        19.6.3. By Time of Action

        19.6.4. By Distribution Channel

    19.7. Germany Injectable Benzodiazepines Market Analysis

        19.7.1. By Drug Class

        19.7.2. By Indication

        19.7.3. By Time of Action

        19.7.4. By Distribution Channel

    19.8. France Injectable Benzodiazepines Market Analysis

        19.8.1. By Drug Class

        19.8.2. By Indication

        19.8.3. By Time of Action

        19.8.4. By Distribution Channel

    19.9. Italy Injectable Benzodiazepines Market Analysis

        19.9.1. By Drug Class

        19.9.2. By Indication

        19.9.3. By Time of Action

        19.9.4. By Distribution Channel

    19.10. Spain Injectable Benzodiazepines Market Analysis

        19.10.1. By Drug Class

        19.10.2. By Indication

        19.10.3. By Time of Action

        19.10.4. By Distribution Channel

    19.11. BENELUX Injectable Benzodiazepines Market Analysis

        19.11.1. By Drug Class

        19.11.2. By Indication

        19.11.3. By Time of Action

        19.11.4. By Distribution Channel

    19.12. Russia Injectable Benzodiazepines Market Analysis

        19.12.1. By Drug Class

        19.12.2. By Indication

        19.12.3. By Time of Action

        19.12.4. By Distribution Channel

    19.13. China Injectable Benzodiazepines Market Analysis

        19.13.1. By Drug Class

        19.13.2. By Indication

        19.13.3. By Time of Action

        19.13.4. By Distribution Channel

    19.14. Japan Injectable Benzodiazepines Market Analysis

        19.14.1. By Drug Class

        19.14.2. By Indication

        19.14.3. By Time of Action

        19.14.4. By Distribution Channel

    19.15. South Korea Injectable Benzodiazepines Market Analysis

        19.15.1. By Drug Class

        19.15.2. By Indication

        19.15.3. By Time of Action

        19.15.4. By Distribution Channel

    19.16. India Injectable Benzodiazepines Market Analysis

        19.16.1. By Drug Class

        19.16.2. By Indication

        19.16.3. By Time of Action

        19.16.4. By Distribution Channel

    19.17. ASEAN Injectable Benzodiazepines Market Analysis

        19.17.1. By Drug Class

        19.17.2. By Indication

        19.17.3. By Time of Action

        19.17.4. By Distribution Channel

    19.18. Australia Injectable Benzodiazepines Market Analysis

        19.18.1. By Drug Class

        19.18.2. By Indication

        19.18.3. By Time of Action

        19.18.4. By Distribution Channel

    19.19. New Zealand Injectable Benzodiazepines Market Analysis

        19.19.1. By Drug Class

        19.19.2. By Indication

        19.19.3. By Time of Action

        19.19.4. By Distribution Channel

    19.20. GCC Countries Injectable Benzodiazepines Market Analysis

        19.20.1. By Drug Class

        19.20.2. By Indication

        19.20.3. By Time of Action

        19.20.4. By Distribution Channel

    19.21. Turkey Injectable Benzodiazepines Market Analysis

        19.21.1. By Drug Class

        19.21.2. By Indication

        19.21.3. By Time of Action

        19.21.4. By Distribution Channel

    19.22. South Africa Injectable Benzodiazepines Market Analysis

        19.22.1. By Drug Class

        19.22.2. By Indication

        19.22.3. By Time of Action

        19.22.4. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

        20.3.1. Regional Footprint by Players

        20.3.2. Product Foot print by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Pfizer Inc.

            21.3.1.1. Overview

            21.3.1.2. Product  Portfolio

            21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.1.4. Sales Footprint

            21.3.1.5. Strategy Overview

                21.3.1.5.1. Marketing Strategy

                21.3.1.5.2. Product Strategy

                21.3.1.5.3. Channel Strategy

        21.3.2. Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

            21.3.2.1. Overview

            21.3.2.2. Product  Portfolio

            21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.2.4. Sales Footprint

            21.3.2.5. Strategy Overview

                21.3.2.5.1. Marketing Strategy

                21.3.2.5.2. Product Strategy

                21.3.2.5.3. Channel Strategy

        21.3.3. Taj Pharmaceuticals Limited

            21.3.3.1. Overview

            21.3.3.2. Product  Portfolio

            21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.3.4. Sales Footprint

            21.3.3.5. Strategy Overview

                21.3.3.5.1. Marketing Strategy

                21.3.3.5.2. Product Strategy

                21.3.3.5.3. Channel Strategy

        21.3.4. Accord Healthcare Ltd

            21.3.4.1. Overview

            21.3.4.2. Product  Portfolio

            21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.4.4. Sales Footprint

            21.3.4.5. Strategy Overview

                21.3.4.5.1. Marketing Strategy

                21.3.4.5.2. Product Strategy

                21.3.4.5.3. Channel Strategy

        21.3.5. Dash Pharmaceuticals LLC

            21.3.5.1. Overview

            21.3.5.2. Product  Portfolio

            21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.5.4. Sales Footprint

            21.3.5.5. Strategy Overview

                21.3.5.5.1. Marketing Strategy

                21.3.5.5.2. Product Strategy

                21.3.5.5.3. Channel Strategy

        21.3.6. hameln pharma ltd

            21.3.6.1. Overview

            21.3.6.2. Product  Portfolio

            21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.6.4. Sales Footprint

            21.3.6.5. Strategy Overview

                21.3.6.5.1. Marketing Strategy

                21.3.6.5.2. Product Strategy

                21.3.6.5.3. Channel Strategy

        21.3.7. F. Hoffmann-La Roche Ltd

            21.3.7.1. Overview

            21.3.7.2. Product  Portfolio

            21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.7.4. Sales Footprint

            21.3.7.5. Strategy Overview

                21.3.7.5.1. Marketing Strategy

                21.3.7.5.2. Product Strategy

                21.3.7.5.3. Channel Strategy

        21.3.8. AdvaCare Pharma

            21.3.8.1. Overview

            21.3.8.2. Product  Portfolio

            21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.8.4. Sales Footprint

            21.3.8.5. Strategy Overview

                21.3.8.5.1. Marketing Strategy

                21.3.8.5.2. Product Strategy

                21.3.8.5.3. Channel Strategy

        21.3.9. Troy Laboratories Pty Ltd

            21.3.9.1. Overview

            21.3.9.2. Product  Portfolio

            21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.9.4. Sales Footprint

            21.3.9.5. Strategy Overview

                21.3.9.5.1. Marketing Strategy

                21.3.9.5.2. Product Strategy

                21.3.9.5.3. Channel Strategy

        21.3.10. Martin Dow

            21.3.10.1. Overview

            21.3.10.2. Product  Portfolio

            21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.10.4. Sales Footprint

            21.3.10.5. Strategy Overview

                21.3.10.5.1. Marketing Strategy

                21.3.10.5.2. Product Strategy

                21.3.10.5.3. Channel Strategy

        21.3.11. Sun Pharmaceutical Industries Limited

            21.3.11.1. Overview

            21.3.11.2. Product  Portfolio

            21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.11.4. Sales Footprint

            21.3.11.5. Strategy Overview

                21.3.11.5.1. Marketing Strategy

                21.3.11.5.2. Product Strategy

                21.3.11.5.3. Channel Strategy

        21.3.12. Intas Pharmaceuticals Limited

            21.3.12.1. Overview

            21.3.12.2. Product  Portfolio

            21.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.12.4. Sales Footprint

            21.3.12.5. Strategy Overview

                21.3.12.5.1. Marketing Strategy

                21.3.12.5.2. Product Strategy

                21.3.12.5.3. Channel Strategy

        21.3.13. Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.)

            21.3.13.1. Overview

            21.3.13.2. Product  Portfolio

            21.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.13.4. Sales Footprint

            21.3.13.5. Strategy Overview

                21.3.13.5.1. Marketing Strategy

                21.3.13.5.2. Product Strategy

                21.3.13.5.3. Channel Strategy

        21.3.14. Akorn Inc

            21.3.14.1. Overview

            21.3.14.2. Product  Portfolio

            21.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            21.3.14.4. Sales Footprint

            21.3.14.5. Strategy Overview

                21.3.14.5.1. Marketing Strategy

                21.3.14.5.2. Product Strategy

                21.3.14.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class

Table 02: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Indication

Table 03: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Time of Action

Table 04: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel

Table 05: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 06: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 07: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 08: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 09: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 10: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 11: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 12: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 13: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 14: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 15: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 16: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 17: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 18: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 19: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 20: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 21: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 22: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 23: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 24: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 25: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 26: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 28: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 29: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 30: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 31: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 32: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 33: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 34: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 35: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 36: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 37: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 38: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 39: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 40: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Injectable Benzodiazepines Market Value Share, By Drug Class, 2019 (A)

Figure 02: Global Injectable Benzodiazepines Market Value Share, By Indication, 2019 (A)

Figure 03: Global Injectable Benzodiazepines Market Value Share, By Time of Action, 2019 (A)

Figure 04: Global Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2019 (A)

Figure 05: Global Injectable Benzodiazepines drugs Market Value Analysis 2015-2021 & 2030

Figure 06: Global Injectable Benzodiazepines drugs Market Y-O-Y Growth Analysis By Region

Figure 07: Global Injectable Benzodiazepines Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 08: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 09: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 10: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Drug Class, 2020 & 2030

Figure 11: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Drug Class, 2020–2030

Figure 12: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020–2030

Figure 13: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Indication, 2020 & 2030

Figure 14: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Indication, 2020–2030

Figure 15: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020–2030

Figure 16: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Time of Action, 2020 & 2030

Figure 17: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Time of Action, 2020–2030

Figure 18: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020–2030

Figure 19: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Distribution Channel, 2020 & 2030

Figure 20: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030

Figure 21: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020–2030

Figure 22: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Region, 2020 & 2030

Figure 23: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 24: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Region, 2020–2030

Figure 25: North America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 26: North America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 27: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 28: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 29: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 30: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 31: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 32: Latin America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 33: Latin America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 34: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 35: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 36: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 37: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 38: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 39: Europe Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 40: Europe Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 41: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 42: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 43: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 44: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 45: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 46: South Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 47: South Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 48: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 49: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 50: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 51: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 52: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 53: East Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 54: East Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 55: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 56: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 57: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 58: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 59: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 60: Oceania Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 61: Oceania Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 62: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 63: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 64: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 65: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 66: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 67: MEA Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 68: MEA Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 69: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 70: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 71: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 72: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 73: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 74: US Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 75: US Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 76: US Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 77: US Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 78: Canada Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 79: Canada Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 80: Canada Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 81: Canada Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 82: Australia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 83: Australia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 84: Australia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 85: Australia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 86: New Zealand Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 87: New Zealand Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 88: New Zealand Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 89: New Zealand Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 90: GCC Countries Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 91: GCC Countries Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 92: GCC Countries Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 93: GCC Countries Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 94: South Africa Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 95: South Africa Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 96: South Africa Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 97: South Africa Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 98: Turkey Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 99: Turkey Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 100: Turkey Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 101: Turkey Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 102: China Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 103: China Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 104: China Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 105: China Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 106: Japan Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 107: Japan Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 108: Japan Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 109: Japan Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 110: South Korea Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 111: South Korea Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 112: South Korea Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 113: South Korea Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 114: India Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 115: India Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 116: India Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 117: India Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 118: ASEAN Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 119: ASEAN Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 120: ASEAN Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 121: ASEAN Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 122: Germany Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 123: Germany Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 124: Germany Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 125: Germany Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 126: Italy Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 127: Italy Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 128: Italy Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 129: Italy Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 130: France Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 131: France Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 132: France Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 133: France Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 134: U.K. Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 135: U.K. Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 136: U.K. Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 137: U.K. Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 138: Spain Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 139: Spain Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 140: Spain Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 141: Spain Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 142: BENELUX Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 143: BENELUX Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 144: BENELUX Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 145: BENELUX Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 146: Russia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 147: Russia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 148: Russia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 149: Russia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 150: Brazil Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 151: Brazil Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 152: Brazil Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 153: Brazil Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 154: Mexico Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 155: Mexico Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 156: Mexico Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 157: Mexico Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Injectable Drugs Market

Published : June 2022

Healthcare

Pharmaceutical Drug Delivery Market

Published : February 2022

Healthcare

Microneedle Drug Delivery Systems Market

Published : November 2020

Healthcare

Injectable Drug Delivery Market

Published : December 2021

Google translate

Injectable Benzodiazepine Market